Kanabo Group - Overview

Kanabo is creating a new standard in the medical cannabis industry by building a holistic ecosystem that works together in synergy to improve the well-being of millions around the world. We focus on the distribution of cannabis-derived products for medical patients, and non-THC products for CBD consumers. We have conducted extensive R&D in order to develop high-quality cannabis oil formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment. Clinical and validation activities, including safety and efficiency tests, are conducted in Israel – an established leader in the cannabis industry.

Registrars:

Key Personnel

CEO: Avihu Tamir
Non-Executive Director: Dan Poulter, Sharon Malka
Deputy Chairman: David Tsur
Non-Executive Chairman: Ian Mattioli

Contact Details

Address: Churchill House, 137-139 Brent Street, London, United Kingdom
Phone: +44 7980 878561
Fax:
Website: http://www.kanabogroup.com/
Email:

Listings

ISIN: GB00BYQCS703
Sector: Health Care, Health Care